EUVIMEDEUVIMED entdecken
Open Access

C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC

Eunsun Jung, Yoon-Jae Kim, Kyoungmin Lee, Seojin Jang, Soeun Park, Eunhye Oh, Minsu Park, Seongjae Kim, Dongmi Ko, Yong Koo Kang, Kee Dal Nam, Lee Farrand und 6 weitere

Oncology Reports · 2025

DOI: 10.3892/or.2025.9018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Eunsun Jung und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152‑703, Republic of Kor…. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Triple Negative Breast Neoplasms, Neoplastic Stem Cells, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP90 Heat-Shock ProteinsTriple Negative Breast NeoplasmsNeoplastic Stem CellsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleCell Line, TumorCell ProliferationAnimalsPhenotypeDrug SynergismMiceXenograft Model Antitumor AssaysCell Movement

Stichwörter der Autor:innen

HSP90 inhibitorNCT‑58cancer stem cellsheat shock responsetriple‑negative breast cancer

Substanzen

HSP90 Heat-Shock Proteins

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152‑703, Republic of Korea.
  • Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 152‑703, Republic of Kore.
  • Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia 5000, Australia.
  • Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.

Zitieren

APA

Jung, E., Kim, Y. J., Lee, K., Jang, S., Park, S., Oh, E., Park, M., Kim, S., Ko, D., Kang, Y. K., Nam, K. D., Farrand, L., Nguyen, C. T., La, M. T., Ann, J., Lee, J., Kim, J. Y., & Seo, J. H. (2025). C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC. Oncology Reports. https://doi.org/10.3892/or.2025.9018

Vancouver

Jung E, Kim YJ, Lee K, Jang S, Park S, Oh E, et al. C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC. Oncology Reports. 2025. doi:10.3892/or.2025.9018

BibTeX
@article{Jung2025,
  author = {Jung, Eunsun and Kim, Yoon-Jae and Lee, Kyoungmin and Jang, Seojin and Park, Soeun and Oh, Eunhye and Park, Minsu and Kim, Seongjae and Ko, Dongmi and Kang, Yong Koo and Nam, Kee Dal and Farrand, Lee and Nguyen, Cong-Truong and La, Minh Thanh and Ann, Jihyae and Lee, Jeewoo and Kim, Ji Young and Seo, Jae Hong},
  title = {C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC},
  journal = {Oncology Reports},
  year = {2025},
  doi = {10.3892/or.2025.9018}
}
Kostenlos starten →